Tag Archives: BMRN

Sangamo Therapeutics Stock History

If you’ve been following the news lately, you might have heard about gene editing, a process that involves rewriting a person’s DNA to correct genetic disorders, and you’re wondering what all the buzz is about.

While gene editing is getting a lot of attention recently, it’s far from a new idea. Sangamo Therapeutics (NASDAQ:SGMO) has been working on gene-editing research....More>>>

Sangamo Therapeutics Stock History

If you’ve been following the news lately, you might have heard about gene editing, a process that involves rewriting a person’s DNA to correct genetic disorders, and you’re wondering what all the buzz is about.

While gene editing is getting a lot of attention recently, it’s far from a new idea. Sangamo Therapeutics (NASDAQ:SGMO) has been working on gene-editing research....More>>>

Top 10 China Stocks To Watch For 2018

Tuesday was another good day on Wall Street, thanks largely to diminished concerns about trade disputes between the U.S. and China. Chinese leaders made conciliatory comments that suggested that there could be a measured resolution to tensions between the two countries, and market participants took that as an all-clear sign to bid shares higher. Yet some stocks suffered from negative news. Tupperware....More>>>

Top 10 High Tech Stocks To Buy For 2018

I was having dinner with friends recently, and someone asked the question, “Stocks are expensive. How should I protect myself in case the market crashes? Should I short something, or maybe use options?”

For most investors, an exotic strategy like one of these isn’t necessary. Instead, you can protect yourself from a stock market correction or crash by keeping some defensive....More>>>

Merrill Lynch’s Top Biotech Acquisition Targets in 2018

Biotechs companies offer big risk, but big reward as well. These are seen as some of the more speculative companies in the market because a single word from governing health care agencies, such as the U.S. Food and Drug Administration (FDA), can make or break these companies.

Analysts often weigh in on these companies, and there are a number of factors that play a role in how analysts view....More>>>

Spark Therapeutics: Earnings Update For This Core Biotech Holding

Shares of Spark Therapeutics (NASDAQ:ONCE) have seen a nice bounce recently, having risen by 30% since late February. It looks like my “buy the dip” piece in late November was followed by a much larger “dip” than I was expecting (Note: This was an unexpected event and great example of how biotech is a minefield).

Figure 1: ONCE daily advanced chart (Source:....More>>>

learn about stock market

Related AAPL PC Shipments Fall Below 63 Million Units For First Time Since 2007 19 Stocks Moving In Wednesday's Pre-Market Session How China And Apple Could Thwart Optical Industry Consolidation (Investor’s Business Daily)

This article originally....More>>>

3 Things In Biotech You Should Learn Today: September 2, 2017

Welcome to another edition of “3 Things In Biotech You Should Learn Today,” a daily digest dedicated to helping you keep up with recent events in the biotech and pharmaceutical industries!

So what’s in store for today?

BioMarin makes itself a priority to the FDA in phenylketonuria

Phenylketonuria is a congenital disorder that can lead to severe complications....More>>>

Top 10 High Tech Stocks To Buy Right Now

On the heels of attending the International Metal Writers conference in Vancouver, BC this week, Nexus Gold Corp (OTC: NXXGF, TSX: NXS.V) is receiving positive coverage of its stock by multiple investment and financial analysis sites. Despite being part of the larger down day on Wall Street today, Nexus Gold’s stock has fared well, particularly in the past 30 days.

....More>>>

Hot Warren Buffett Stocks To Own Right Now

The going rate for a lunch date with Warren Buffett: $2,679,001.

At least, that’s how much the top bidder — who wished to remain anonymous — in this year’s “Power Lunch with Warren Buffett” charity auction was willing to pay. The bidding closed Friday evening.

This is the 18th year Buffett has offered himself up for the bidding war, and he does....More>>>